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Crystal structure of Escherichia coli lytic transglycosylase Slt35
reveals a lysozyme-like catalytic domain with an EF-hand
Erik J van Asselt1, Arnoud J Dijkstra2, Kor H Kalk1, Bela Takacs2,
Wolfgang Keck2 and Bauke W Dijkstra1*
Background: Lytic transglycosylases are bacterial muramidases that catalyse
the cleavage of the β-1,4-glycosidic bond between N-acetylmuramic acid
(MurNAc) and N-acetylglucosamine (GlcNAc) in peptidoglycan with
concomitant formation of a 1,6-anhydrobond in the MurNAc residue. These
muramidases play an important role in the metabolism of the bacterial cell wall
and might therefore be potential targets for the rational design of antibacterial
drugs. One of the lytic transglycosylases is Slt35, a naturally occurring soluble
fragment of the outer membrane bound lytic transglycosylase B (MltB) from
Escherichia coli.
Results: The crystal structure of Slt35 has been determined at 1.7 Å resolution.
The structure reveals an ellipsoid molecule with three domains called the alpha,
beta and core domains. The core domain is sandwiched between the alpha and
beta domains. Its fold resembles that of lysozyme, but it contains a single metal
ion binding site in a helix–loop–helix module that is surprisingly similar to the
eukaryotic EF-hand calcium-binding fold. Interestingly, the Slt35 EF-hand loop
consists of 15 residues instead of the usual 12 residues. The only other
prokaryotic proteins with an EF-hand motif identified so far are the D-galactose-
binding proteins. Residues from the alpha and core domains form a deep
groove where the substrate fragment GlcNAc can be bound.
Conclusions: The three-domain structure of Slt35 is completely different from
the Slt70 structure, the only other lytic transglycosylase of known structure.
Nevertheless, the core domain of Slt35 closely resembles the fold of the
catalytic domain of Slt70, despite the absence of any obvious sequence
similarity. Residue Glu162 of Slt35 is in an equivalent position to Glu478, the
catalytic acid/base of Slt70. GlcNAc binds close to Glu162 in the deep groove.
Moreover, mutation of Glu162 into a glutamine residue yielded a completely
inactive enzyme. These observations indicate the location of the active site and
strongly support a catalytic role for Glu162.
Introduction
The shape and strength of the bacterial cell is largely deter-
mined by its cell wall [1]. The bacterial cell wall is made up
of peptidoglycan, which, as a single molecule, surrounds
the entire cell and protects the bacterium from the high
internal osmotic pressure. Peptidoglycan consists of
oligomeric glycan strands of alternating N-acetylglu-
cosamine (GlcNAc) and N-acetylmuramic acid (MurNAc)
residues cross-linked by short oligopeptide chains of alter-
nating L-amino and D-amino acids. To keep the cell wall
intact during cell growth and division, a large number 
of peptidoglycan-metabolising enzymes works closely
together to prevent rupture of the cell wall and cell lysis [2].
Given that peptidoglycan is essential, unique for prokary-
otes and easily accessible, the peptidoglycan-metabolising
enzymes constitute effective targets for antibacterial com-
pounds. For example, penicillin and related β-lactam
antibiotics inhibit the enzymes that are responsible for the
making and breaking of the peptide cross-linkages [3].
Unfortunately, the widespread use of antibiotics over the
years has enhanced the development of resistance in many
bacteria. An intensive search for new antibacterial agents
has therefore been initiated to overcome the problem of
resistance [4]. Suitable targets for such new drugs could be
β-lactam insensitive peptidoglycan-metabolising enzymes,
such as the lytic transglycosylases.
Lytic transglycosylases catalyse the cleavage of the
β-1,4-glycosidic bond between MurNAc and GlcNAc
residues in peptidoglycan with concomitant formation of a
1,6-anhydrobond between the O6 and C1 atoms in the
MurNAc residue [5]. They are believed to function as
space makers to allow the insertion of new peptidoglycan
material into the cell wall during growth [6]. Moreover,
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they are involved in making pores in the peptidoglycan
layer to allow transport of DNA and proteins across the cell
wall [7], and they have been proposed to act as cell wall
zippers during cell division [8]. Because lytic transglycosy-
lases are able to completely degrade peptidoglycan to
1,6-anhydromuropeptides in vitro, their activity in vivo has
to be strictly controlled [8]. The regulation of their activity
is not understood in detail. It has been suggested that
transglycosylases closely cooperate with peptidoglycan-
synthesising enzymes [9] or may be bound to them acting
together as peptidoglycan-metabolising complexes [10,11].
The importance of lytic transglycosylases for the cell wall
metabolism of Escherichia coli is indicated by the identifi-
cation of one soluble (Slt70 [5]) and five membrane-
bound lytic transglycosylases (MltA–D and EmtA
[12–19]). They differ in size, sequence, activity, speci-
ficity and location. Homologous genes have been identi-
fied in many Gram-negative and Gram-positive bacteria
[7,20,21]. Structural research on lytic transglycosylases
has resulted so far in the crystal structures of the 70 kDa
soluble lytic transglycosylase Slt70 [22] and its complex
with the inhibitor bulgecin A [23], a naturally occurring
glycopeptide produced by Pseudomonas acidophila and
Pseudomonas mesoacidophila. Bulgecin is a specific inhibitor
of the lytic transglycosylases Slt70 [24], MltC and MltD
[18], but not of MltA or MltB.
MltB is of special interest because both a membrane-
bound form and a soluble form have been identified in 
E. coli [14–16]. The membrane-bound enzyme is a 40 kDa
lytic transglycosylase of 361 amino acid residues. Its amino
acid sequence does not show obvious homology to that of
Slt70 [15,16]. Furthermore, it is a lipoprotein that is
anchored to the outer membrane via a lipid anchor
attached to Cys19. The lipid anchor probably acts as a
safety measure to prevent direct degradation of the cell
wall [16]. Slt35 is a naturally occurring soluble 36 kDa pro-
teolytic fragment of MltB, formed when the first 39 amino
acid residues are cleaved off [14–16]. This stable fragment
has been successfully overexpressed and purified [15], and
it is fully active as shown by zymogram and high pressure
liquid chromatography (HPLC) analysis [15].
In this article we describe the crystal structure of Slt35.
One of its three domains shows a lysozyme fold and a
metal ion binding site that surprisingly resembles EF-hand
calcium-binding domains. Furthermore, a soaking experi-
ment revealed the binding of the monosaccharide GlcNAc
in a deep groove close to a conserved glutamate residue,
which is proposed to function as the catalytic acid/base
during the cleavage and transglycosylation reaction.
Results and discussion
Structure determination and description
The crystal structure of native Slt35 has been solved by
the multiple isomorphous replacement method with sub-
sequent refinement at 1.7 Å resolution to a final crystallo-
graphic R factor of 17.8%. Tables 1 and 2 and the
Materials and methods section give pertinent details on
the structure determination. The final model contains 312
amino acid residues (40–98 and 109–361) with alternate
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Table 1
Data collection and phasing statistics.
Data set Native GlcNAc Os-I* Pb-I* Hg-I* Hg-II* Hg-III*
Data collection
Soaking
concentration (mM) – Saturated 3.0 12 3.0 2.0 3.0
time – 18 min 4 days 24 h 6 days 8 days 2 h
Resolution range (Å) 30–1.70 25–2.45 34–3.00 34–3.44 34–2.69 34–2.70 18–2.02
No. of reflections
total 206,582 49,117 23,113 21,880 20,201 23,732 92,150
unique 43,117 14,836 7954 5096 9063 9339 24,767
Completeness (%) 97.6 98.4 96.6 91.8 80.0 82.6 94.0
Rmerge (%)† 5.0 10.4 5.6 7.4 3.7 4.2 3.8
Rnat (%)‡ 9.3 6.0 6.2 7.1 6.9
Phasing statistics
Number of sites 4 2 7 5 6
Phasing power§
iso 1.29 0.97 1.56 1.39 0.88
ano 0.51 0.37 0.69 0.69 1.20
RCullis¶ 0.578 0.657 0.552 0.608 0.657
Figure of merit (overall)# 0.604
*Os-I, K2OsO4•2H2O; Pb-I, trimethyllead acetate; Hg-I, parachloromercury-phenylsulphonic acid; Hg-II, parachloromercury-benzoic acid; Hg-III,
2-chloromercury-4-nitrophenol. †Rmerge = Σ|I–<I>|/ΣI. ‡Rnat = Σhkl|(FP–FPH)|/Σhkl 0.5(FP + FPH). §Phasing power = Σhkl |FH(calc)|/Σhkl ||FPH| – |FPH(calc)||.
¶RCullis = Σhkl ||FPH ± FP | – FH(calc)|/Σhkl |FPH ± FP|. #For 10,418 reflections from 24.0 to 2.70 Å.
sidechain conformations for 15 residues (Asp74, Ile81,
Ser83, Lys86, Leu94, Asp139, Trp145, Glu153, Ile155,
Ser193, Met202, Arg204, Phe217, Asp269 and Gln311).
The sidechain of the first N-terminal residue Met40 and
an internal stretch of ten residues (99–108) do not show
interpretable electron density in Fo–Fc and 2Fo–Fc omit
maps and have been omitted from the model. To examine
whether the crystallised protein had been cleaved, Slt35
crystals were dissolved and analysed by sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS–PAGE).
No cleavage of the protein was observed (data not shown).
Slt35 is very rich in α helices, but has some short β strands
as well. In total, 49% of all observed 312 amino acid residues
are found in 14 α helices (H1–H14), and 10% of the amino
acids are found in seven β strands (S1–S7) forming two
β sheets (Figures 1,2). The remaining residues are found in
β turns and γ turns, loops and two 310 helices. The three-
dimensional structure of Slt35 is built up of three well-
defined domains named the alpha, beta and core domains,
and has dimensions of approximately 35 Å × 45 Å × 75 Å.
The alpha domain
The alpha domain of Slt35 is at the bottom of the structure
in the orientation shown in Figure 1 and can be considered
to be built up of two subdomains. The first subdomain
comprises residues 40–98 and the three α helices H1, H2
and H3. Residues 40–50 are very flexible as indicated by
high mean atomic displacement parameters (49 Å2 for the
mainchain and 50 Å2 for the sidechain atoms, compared
with mean B factors of 21 Å2 and 24 Å2 for all mainchain
and sidechain atoms, respectively). This stretch of residues
is only connected to the alpha domain by hydrogen bonds
between the carbonyl oxygen atom of Val47 and the Nε2
atoms of Gln76 and Gln79. In the full MltB protein it
might have a different conformation or be part of the flexi-
ble linker that anchors the enzyme to the outer membrane.
The second subdomain includes residues 170–215, which
form a hairpin-like structure. The hairpin sequentially
consists of the short β strand S1 (residues 172–173),
α helix H8 (174–183), 310 helix (186–188), α helix H9
(189–205), 310 helix (210–212) and short β strand S2
(residues 214–215), in which the two strands form a small
antiparallel β sheet. The accessible surface area buried by
the interaction of the two subdomains is substantial,
1000 Å2. The major part of this buried interface consists of
hydrophobic residues with significant contributions from
alanine, leucine and phenylalanine residues.
Comparisons of various MltB sequences show that the
residues in the N-terminal subdomain are not conserved,
whereas the residues in the hairpin subdomain display a
conservation of about 43% (Figure 2). According to the
DALI server [25] the overall fold of the alpha domain does
not show similarity to any other protein. 
The beta domain
The beta domain is located above the core domain of
Slt35 (Figure 1). It consists of residues 270–329, which
form a five-stranded antiparallel β sheet (S3–S7) that is
flanked by one short α helix (H12) of six residues
(292–297). As with the alpha domain, the beta domain
seems to have a new overall fold; no similar structures
could be identified by the DALI server [25]. The buried
surface area between the beta domain and the core
domains is large, 820 Å2, with only three residues (Asp318,
Tyr323 and Leu329) making hydrogen bonds to the core
domain. The remaining interactions are hydrophobic.
The core domain
The core domain of Slt35 is sandwiched between the
alpha and beta domains. It can be considered to consist of
three segments (residues 109–169, 216–269 and 330–361).
The residues between the first and second segment
(residues 170–215) make up the second subdomain of the
alpha domain and the beta domain is inserted between
segment two and three. The first segment is made up of
the four α helices H4, H5, H6 and H7. Residues 111 to
114 are anchored via their backbone amide nitrogen atoms
to the carboxylate group and backbone carbonyl oxygen
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Table 2
Refinement statistics.
Data set Native GlcNAc
Resolution range (Å) 20.0–1.70 20.0–2.45
No. of reflections
total 41,498 14,679
work set 37,284 13,196
test set 4214 1483
Final R factor (%)* 17.8 19.5
Rwork factor (%)† 17.6 19.1
Rfree factor (%)‡ 20.7 25.6
Rmsd
bond lengths (Å)§ 0.008 0.006
bond angles (°)§ 1.3 1.2
dihedral angles(°)§ 22.2 22.1
improper angles(°)§ 1.21 1.05
Non-hydrogen protein atoms 2550 2507
Residues 312 312
Alternate sidechains 15 4
Solvent molecules 426 201
Bicine molecule 1 0
Ethylene glycol molecule 1 0
Metal ion 1 1
GlcNAc molecule 0 1
Average B factor (Å2)
Wilson plot 19.1 19.5
mainchain 20.5 20.9
sidechains 23.5 21.6
all atoms 24.6 21.8
*Final R factor = Σhkl (| Fo(hkl, all) | – | Fc(hkl, all) |) /Σhkl | Fo(hkl, all) |.
†Rwork factor = Σhkl(| Fo(hkl, work set) | – | Fc(hkl, work set) |) /Σhkl |
Fo(hkl, work set) |. ‡Rfree factor = Σhkl(| Fo(hkl, test set) | – | Fc(hkl, test
set) |) /Σhkl | Fo(hkl, test set) |. §With respect to the Engh and Huber
parameters [68].
1170 Structure 1999, Vol 7 No 10
Figure 1
Stereoviews of Slt35. (a) Cα trace with bicine
and ethylene glycol (Egl) molecules in the
active-site groove. Every tenth amino acid
residue is labelled. (b) Ribbon plot with
GlcNAc shown in the active-site groove. The
alpha domain (green) is at the bottom of the
molecule, the beta domain (red) is at the top
and the core domain (yellow) is in the centre.
The EF-hand loop (residues 237–245) with the
metal ion is depicted in blue. The secondary
structure elements are labelled H1–H14 for
the α helices and S1–S7 for the β strands. The
proposed catalytic acid/base Glu162 and the
GlcNAc molecule are indicated in ball-and-
stick representation. The figure was produced
with the program MOLSCRIPT [64].
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Figure 2
Multiple sequence alignment, generated with CLUSTAL [65] and
ALSCRIPT [66], of MltB lytic transglycosylases from Escherichia
coli, Salmonella typhimurium, Yersinia pestis (two different MltBs
labelled 1–2), Pseudomonas aeruginosa (four different MltBs
labelled 1–4), Bordetella pertussis, Neisseria gonorrhoeae,
Neisseria meningitidis and Haemophilus actinomycetemcomitans.
The sequences were obtained using the BLAST server at the
National Center for Biotechnology Information [67]. The residue
numbering of E. coli MltB is displayed at the top of the alignment and
the different domains and secondary structures in Slt35 are
indicated at the bottom. The conserved catalytic acid/base Glu162
of Slt35 is marked with an arrow. The domain nomenclature refers to
the MltB of E. coli. The alpha domain consists of residues 40–98
and 170–215, the beta domain of residues 270–329 and the core
domain of residues 109–169, 216–269 and 330–361. Identical
residues are shown as white letters on a black background;
conserved residues are shaded in grey.
atom of Asp318, located at the end of β strand S6 in the
beta domain. In the second segment (residues 216–269),
the loop that connects α helices H10 (residues 228–234)
and H11 (residues 249–262) binds a metal ion (see below).
The residues in this loop and α helix H10 are the only
residues in the core domain that make hydrogen bonds to
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residues in the alpha domain (Pro228 and Ser229 with
Glu195, and Tyr231 and Ile244 with Glu206). The buried
surface between the alpha and the core domain is about
760 Å2. The third segment contains the C-terminal
residues 330–361 and the α helices H13 and H14, which
provide the major interactions with the beta domain. The
overall fold of the core domain resembles those of the
goose-type lysozyme [26] and the catalytic domain of
Slt70 [27] (see below).
A novel EF-hand motif
A metal ion is bound in the loop that connects α helices
H10 and H11. Figure 3a shows the distorted octahedral
coordination of the metal ion, which is ligated by six
protein oxygen atoms (Oδ1 of Asp237, Oγ of Ser239, Oδ1
of Asp241, O of His243, Oδ1 and Oδ2 of Asp251) at an
average distance of 2.4 Å. A water molecule is located at
3.3 Å from the metal ion. The polypeptide chain con-
tributing these residues has a conformation that resembles
the EF-hand calcium-binding domains commonly found
in eukaryotic intracellular calcium-binding proteins, like
calmodulin and parvalbumin [28,29]. In general, EF-hand
domains consist of a 12-residue loop flanked on both sides
by an α helix. In Slt35, however, the loop consists of
15 residues. The interhelical angle between α helices H10
and H11 is 75°, which is close to the range of 84–101°
observed for the EF-hand domains in calmodulin [30] and
carp parvalbumin B [28]. Nevertheless, as is evident from
Figure 3d, α helices H10 and E are oriented differently
with respect to the superimposed calcium-binding loops,
and α helix H11 has been translated.
In typical EF-hand loops, the calcium ion is coordinated
in a pentagonal bipyramidal configuration, whereby
usually six residues contribute to the binding of the ion
[28,29]. These residues are located in positions 1, 3, 5, 7, 9
and 12 of the EF-hand calcium-binding consensus
sequence (Figure 4). The residue at position 7 ligates the
calcium with its carbonyl oxygen atom, whereas the other
residues contribute with their sidechain oxygen atoms to
the metal ion coordination. The residues of Slt35 conform
to this consensus motif with the exception of Asn245 at
position 9 and Asp248 at position 12. The sidechain
oxygen atom of Asn245 is hydrogen bonded to the amide
nitrogen of Trp247 and is too far away (7.9 Å) to be a pos-
sible ligand. The ligating residue at position 9 shows great
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Figure 3
The metal ion binding sites in (a) Slt35 and
(b) carp parvalbumin B (PDB entry code
5cpv). (c,d) Superposition of the metal ion
binding sites in Slt35 and parvalbumin B. Part
(c) shows a close-up of the binding site, (d)
shows the orientation and position of the EF-
hand helices in the two proteins. Residues
90–98 of parvalbumin B (green) were
superimposed on residues 237–245 of Slt35
(blue) with an rmsd of 0.32 Å2 for nine Cα
atoms. Residues of Slt35 that were not used
in the superposition are shown in yellow.
Helices E and F (green) belong to parvalbumin
and the α helices H10 and H11 (yellow) are
from Slt35. 
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variability in other EF-hand calcium-binding domains as
well. Often it is a water molecule bound between the
metal ion and a sidechain residue as observed in the
second EF-hand domain of carp parvalbumin B [28], for
example. In Slt35, there is also a water molecule at this
position, but it is 3.3 Å from the ion, too far away to be a
coordinating ligand. The metal ion in EF-hand domain of
Slt35 is therefore missing a ligand at position 9.
Asp248 at position 12 is not ligating the ion either; its role
has been taken over by the sidechain of Asp251 at position
15, which occupies a position equivalent to the calcium-
binding glutamate residue at position 12 in parvalbumin B.
Both residues are the third residue of the C-terminal 
α helix of the EF-hand domain. A superposition of the EF-
hand domains of carp parvalbumin B and Slt35 shows that
in Slt35 the ion-binding loop starts to deviate after position
9 and that three extra residues are inserted (Figure 3c).
This results in a translation of the C-terminal α helix of the
EF-hand domain (Figure 3d). This is the first time that
such a variation of the EF-hand motif is observed.
A sequence comparison shows that other MltB transglyco-
sylases also conform to the EF-hand consensus motif
(Figures 2,4). The aspartate residue at position 1 and the
glycine residue at position 6 are strictly conserved,
whereas the –Z ligand varies from position 15 to 16
because of an insertion of one extra residue between posi-
tions 11 and 12 (Figure 4). The glycine residue at position
6 has φ/ψ angles that are not allowed for other amino acid
residues (φ = 90.8°, ψ = –4.7°) and might be important for
the conformation of the metal ion binding loop. At posi-
tions 3, 5, 9 and 12, serine, asparagine or aspartate residues
can be present. The residue at position 10 is either leucine
or isoleucine. In Slt35, the sidechain of this residue
(Leu246) forms a hydrophobic cluster together with the
conserved residues Ile174, Met221, Phe226 and Trp247.
This indicates the conservation of the Slt35 EF-hand
domain in all MltB transglycosylases.
The resemblance of the ion-binding site in Slt35 to the
EF-hand calcium-binding domains suggests that a calcium
ion is bound. Although the average ion ligand distance is
2.4 Å, which is typical for calcium–oxygen distances [31],
we cannot rule out that a sodium ion has bound to the ion-
binding site, as sodium–oxygen distances are also 2.4 Å
[31]. Moreover, sodium, but not calcium, was present in
the crystallisation solutions. Refinement of the metal ion
as a sodium ion resulted in an atomic displacement para-
meter (16.0 Å2) that is much closer to the average atomic
displacement parameter of the ligands (15.5 Å2) than
when refined as a calcium ion (26.7 Å2). When an Slt35
crystal was soaked in mother liquor with 1 mM CaCl2,
however, the sodium ion was clearly replaced by a calcium
ion [32]. As the calcium ion concentration in the periplasm
is in the order of 0.1–1.0 mM [33], it is probable that the
naturally bound ion is a calcium ion.
Function of the calcium-binding site
In eukaryotic proteins, EF-hand calcium-binding domains
can be involved in calcium sensoring, signal transduction,
contraction, secretion, protein–protein recognition and cell
proliferation [29,34,35]. So far only one other prokaryotic
EF-hand-like domain has been described, occurring as a
single domain in the periplasmic D-galactose-binding pro-
teins from E. coli [36] and Salmonella typhimurium [37]. As
in Slt35, this domain does not conform to the canonical
EF-hand consensus sequence [29,36]; it contains two
polypeptide stretches (residues 134–142 and 204–205) that
are distant in the primary structure contributing to the
calcium ligation [36]. The function of this domain has not
been established but it might have a structural rather than
regulatory role [36].
The function of the EF-hand domain in Slt35 is not clear
either. As the calcium site is 20 Å from the active site (see
below), a direct role in the reaction mechanism seems
unlikely. Introduction of a calcium site in the human
lysozyme at a position equivalent to the EF-hand calcium
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Figure 4
Multiple sequence alignment of the EF-hand
motifs of carp parvalbumin B and the MltB
transglycosylases from Escherichia coli and
Neisseria gonorrhoea. Residues X, Y, Z, –X
and –Z coordinate the metal ion with their
sidechain oxygen atoms. In some cases, a
bridging water molecule is present between the
sidechain and the ion. Residue –Y supplies a
mainchain carbonyl oxygen atom as ligand and
the carboxylate at –Z coordinates the metal ion
with both oxygen atoms. X and –X define the
unique axis of a pentagonal bipyramid [29]. The
positions 11a and 11b refer to the insertion of
an extra residue in the EF-hand of some MltBs
in the sequence alignment of Figure 2.
  Carp parvalbumin B    50 D  Q  D  K  S  G  F  I  E  -  -  -  -  E  D  E  62
  Carp parvalbumin B    89 D  S  D  G  D  G  K  I  G  -  -  -  -  V  D  E 101
  MltB from E. coli    237 D  F  S  G  D  G  H  I  N  L  W  -  D  P  V  D 251
  MltB from N. gono    233 D  Y  D  G  D  G  H  R  D  I  W  G  N  V  R  D 248
  Coordination             X     Y     Z    -Y    -X                   -Z
  Position                 1  2  3  4  5  6  7  8  9 10 11 11 12 13 14 15
  Consensus pattern        D  F  D  G  D  G  H  I  D  L  W  G  D  P  V  D
  for EF-hand calcium-        G  N  D  N     K  R  N  I  T  N  N  V  G 
  binding domains in MltBs    Y  S  N        R  K        V  S  S  I  R
                                    S        E              T     H  T
                                                                     D
                                                                     A
                                                                     Y
                                                                     P
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site in Slt35 (Figure 5a) increased the stability of the
enzyme against protease digestion and thermal denatura-
tion [38]. Such a structural function might also be possible
for Slt35. Alternatively, calcium binding might be impor-
tant for the correct folding of MltB in the periplasmic
space. Finally, the EF-hand domain might be involved in
interactions of MltB transglycosylases with other proteins
such as the penicillin-binding proteins [11].
Comparison with Slt70
Despite the lack of obvious sequence similarity, the core
domain of Slt35 clearly resembles the fold of the C-terminal
catalytic domain of Slt70, the 70 kDa soluble lytic transgly-
cosylase from E. coli [22,27]. The two domains can be super-
imposed with a root mean square deviation (rmsd) of 1.7 Å
for 100 Cα atoms (Figure 5b). A structure-based sequence
alignment shows that 23 of the 100 superimposed residues
are identical (data not shown). The large excursions into the
alpha and beta domains, and the absence in Slt35 of the
Slt70 α helices Cα6 and Cα7 and the C-terminal tail pre-
cluded a successful sequence alignment of Slt35 and Slt70
in the past. Furthermore, Slt35 lacks the characteristic
sequence motifs found in other lytic transglycosylases [7,20]
also hampering a successful sequence alignment. This lack
of obvious homology reflects the pronounced sequence vari-
ability and diversity in the lytic transglycosylase family.
Identification of the active site
The large groove between the alpha domain and the core
domain is lined with the aromatic residues Tyr117, Phe121,
Tyr191, Phe192, Phe217, Phe226, Tyr234, Tyr259, Tyr338
and Tyr344. A multiple sequence alignment of MltB trans-
glycosylases from various species shows that the aromatic
character of most of these residues is conserved (Figure 2).
As aromatic residues in enzymes have often been found to
interact with sugar residues in peptidoglycan, chitin and
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Figure 5
Structural comparisons with Slt35.
(a) Stereoview superposition of the Cα traces
of Slt35 (residues 129–361; thick black line)
and human D86/92 lysozyme (residues
1–130; thin black line; PDB entry code 3lhm).
The rmsd for 78 superimposed Cα atoms is
2.1 Å. The catalytic acid/base Glu162 of Slt35
and Glu35 of lysozyme are indicated. The
metal ions in Slt35 and lysozyme are coloured
in black and grey, respectively. (b) Stereoview
superposition of the Cα traces of Slt35
(residues 137–361; thick black line) and the
Slt70 catalytic domain (residues 453–618;
thin black line). Glu162 and Ser216 of Slt35
and Glu478, Ser487 and Glu583 of Slt70 are
indicated. The alignments were performed with
the LSQ options in the program O [57]. This
figure was made with the program
MOLSCRIPT [64]. 
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starch [23,39,40], this suggests that the groove of Slt35 is
designed to bind the peptidoglycan glycan strands and that
the active site is located in this groove. 
Superposition of the Slt35 core domain on the catalytic
domain of Slt70 shows that Glu162 of MltB superimposes
on Glu478 of Slt70 (Figure 5b). As Glu478 acts as the cat-
alytic acid/base in Slt70 [27], this suggests that Glu162
could be the catalytic acid/base in Slt35. Indeed, a
Glu162→Gln mutation results in a completely inactive
enzyme (data not shown). The environment of Glu162 is
largely hydrophobic stabilising the protonated state of this
residue. It is surrounded by the sidechains of Ile158,
Gln225, Tyr338 and Tyr344. These residues are not only
conserved in Slt35 and Slt70, but also in the MltBs from
other species. The Tyr344 hydroxyl group makes a strong
hydrogen bond of 2.6 Å to one of the Oε atoms of Glu162.
In Slt70, the equivalent Tyr587 makes a similar hydrogen
bond to the acid/base catalyst Glu478.
Previously, attempts to locate the active site of MltB using
the lytic transglycosylase sequence motifs of Slt70 [20,41]
had suggested Glu206 as the catalytic acid/base [15]. A
Glu206→Gln mutation had no effect on the activity of MltB
[18]. In our structure, Glu206 is located at the surface of the
alpha domain in the loop after α helix H9, distant from the
putative active site (see Figure 1 for example) explaining
the absence of adverse effects on the enzyme activity.
The Slt35–GlcNAc complex
To analyse whether sugars can be bound in the active site,
the structure of an Slt35–GlcNAc complex was deter-
mined at 2.45 Å resolution (Table 2). The model has 201
water molecules, one sodium ion, one GlcNAc molecule
and alternate sidechain conformations of Asp74, Trp145,
Glu153 and Arg204. The GlcNAc sugar has been mod-
elled in a full 4C1 chair conformation (Figure 6). It is
located in the active-site cleft at a distance from the cat-
alytic Glu162, which corresponds to substrate-binding site
–2 [42]. No electron density was observed that could
account for other GlcNAc molecules bound in the groove.
Its O1-hydroxyl group is in a β-anomeric configuration
making a water-mediated hydrogen bond to the backbone
carbonyl oxygen atom of Gln225. The nitrogen atom of
GlcNAc forms a hydrogen bond to the backbone carbonyl
oxygen atom of Tyr338 (3.1 Å), whereas the oxygen atom
of the N-acetyl group makes hydrogen bonds with the
mainchain NH of Met227 (3.1 Å) and the Oγ of Ser230
(2.8 Å). Other hydrogen bonds are present between the
C3-hydroxyl group and the Tyr259 hydroxyl group (2.8 Å),
and between the C4-hydroxyl group and the Nε2 of
His340 (3.1 Å). The hydroxyl group of the C6 atom has no
direct contacts with protein atoms.
Comparison of the native Slt35 and Slt35–GlcNAc struc-
tures shows that a bicine buffer molecule is bound in the
native Slt35 structure at a position equivalent to that of
the sugar in the Slt35–GlcNAc complex (Figure 6). One of
the ethylhydroxy groups of the bicine molecule mimics
the position of the GlcNAc N-acetyl oxygen atom with
hydrogen bonds to the backbone NH of Met227 (3.0 Å)
and the Oγ of Ser230 (2.6 Å). The other ethylhydroxy
group makes hydrogen bonds to the backbone carbonyl
oxygen of Gln225 (2.7 Å) and a water molecule (3.1 Å).
Furthermore, the bicine molecule has hydrophobic inter-
actions with the aromatic rings of Phe226, Tyr259 and
Tyr338 that are similar to those of the N-acetylmethyl
group (C8) of GlcNAc.
Figure 6e shows that the mainchain atoms of Tyr338,
Asn39 and His340, located above the active-site cleft,
have moved 0.5–0.6 Å towards the GlcNAc sugar, to form
hydrogen bonds to the N2 and O4 atoms of GlcNAc,
respectively. Small active-site movements and the forma-
tion of hydrogen bonds between the N-acetyl group of
GlcNAc in site –2 and the protein have also been observed
in the phage T4 lysozyme–murotetrapeptide complex
[43], the Slt70–bulgecin complex [23] and the hen egg
white lysozyme–GlcNAc complex [44].
Beside bicine, an ethylene glycol molecule has been iden-
tified in the active-site groove (Figure 6). It is bound in
front of sugar-binding site –1 at the interface between the
alpha and core domains about 10 Å from Glu162 and its
hydroxyl groups are hydrogen bonded to the Nη1 (3.1 Å)
and the Nη2 atoms (2.8 Å) of Arg188. Its carbon atoms
have hydrophobic interactions with the Cε and Sδ of
Met227 and the Cβ of Ala218. Arg188 and Ala218 are con-
served in all MltB transglycosylases, whereas in one case
there is an isoleucine residue instead of a Met227 residue
(Figure 2). Modelling studies (on the basis of the T4
lysozyme–murotetrapeptide complex [45]) suggest that
the ethylene glycol molecule has bound at a position
where the D-lactyl group of a MurNAc residue in site –1
might be bound (not shown).
Peptidoglycan binding and reaction mechanism
Enzyme–substrate binding studies have shown the pres-
ence of five or six sugar-binding sites in the active-site
cleft of various lysozymes [42]. The cleft of Slt35 is shorter
than that in other lysozymes and seems to have only four
sugar-binding sites: those at positions –2, –1, +1 and +2.
Sites –3 and –4 seem to be absent because no clear sugar-
binding sites are present. Preliminary modelling studies
show that MurNAc residues cannot bind at the –2 and +1
sites because of clashes of the D-lactyl group with Slt35
residues. Therefore, MurNAc has to bind in site –1, which
explains why the enzyme is a muramidase.
In the proposed reaction mechanism of Slt70 [23], cleav-
age of the glycosidic bond between the C1 atom of
MurNAc in site –1 and the O4 atom of GlcNAc in site +1
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Figure 6
Bicine, ethylene glycol and GlcNAc in the
active-site cleft of Slt35. The σA-weighted
Fo–Fc electron density omit maps are
superimposed on (a) the bicine and ethylene
glycol molecules in the native Slt35 structure
and (b) the GlcNAc molecule in the
Slt35–GlcNAc complex. The omit maps are
contoured at 3.0σ. The densities have been
calculated from the final models excluding the
particular molecule(s). The substrate atoms,
Glu162 and Arg188 are represented in ball-
and-stick representation with carbon atoms in
black, nitrogen atoms in light grey, oxygen
atoms in white and sulphur atoms in dark grey.
(c) Stereoview of the binding interactions of
bicine and ethylene glycol. Hydrogen bonds
are shown as dashed lines. (d) Stereoview of
the binding interactions of the GlcNAc
molecule in the active site. (e) Superposition
of the active sites of the native Slt35 structure
(thin black line) and the Slt35–GlcNAc
complex after superposition of their Cα atoms
(rmsd of 0.27 Å for 312 Cα atoms).
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is assumed to result in the formation of an oxo-carbonium
ion-like transition state on the –1 MurNAc residue. This
reaction intermediate state could be stabilised by the
2-acetamido group of the –1 MurNAc residue. In Slt70,
residues Ser487 and Glu583 contribute to the correct ori-
entation and stabilisation of the 2-acetamido group by
hydrogen bonding to the 2-acetamido oxygen and nitro-
gen atoms [23]. Such a substrate-assisted stabilisation has
also been described for the plant chitinase hevamine [46]
and the Serratia marcescens chitobiase [47], in which car-
boxylate and hydroxyl groups also help to orient the
2-acetamido group in a similar manner. Residue Ser216 of
Slt35 superimposes on Ser487 of Slt70, but surprisingly
there is no residue in a position equivalent to that of
Glu583 in Slt70. Whether this difference is of functional
importance for the catalytic mechanism or regulation of
the activity requires further investigation.
Exo-muramidase activity
Slt35 is an exo-muramidase that cleaves 1,6-anhydro-
muropeptides from the non-reducing GlcNAc end of
peptidoglycan strands processing towards the 1,6-anhy-
dromuramate end [48]. Slt70 is also an exo-muramidase
[48] and it has been proposed that the doughnut-shaped
N-terminal domain of Slt70 is responsible for its activity
as an exo-enzyme [22]. Slt35 lacks such a doughnut-
shaped domain, but instead the disordered residues
99–108 might partly cover the active site (Figure 7) and
thus might prevent endo-activity of the enzyme. Addi-
tionally, this exo-loop might cause steric hindrance with
the peptide crossbridges in the peptidoglycan and this
might restrict the activity of Slt35 to peptidoglycan with
either no degree or a low degree of cross-linking.
Biological implications
An intact cell wall is of vital importance for the survival
of bacteria. Compounds that interfere with the strictly
regulated activity of the enzymes involved in the synthe-
sis and degradation of the cell wall peptidoglycan have
been found to be effective antibiotics. Whereas penicillin
and related β-lactam antibiotics inactivate the enzymes
that make and break the peptide bonds in the peptidogly-
can, only a few inhibitors are known for the enzymes
that act on the glycan strands of peptidoglycan.
Lytic transglycosylases catalyse the cleavage of the β-1,4-
glycosidic bond between an N-acetylmuramic acid
(MurNAc) residue and N-acetylglucosamine (GlcNAc)
residue in peptidoglycan with concomitant formation of a
1,6-anhydrobond between the O6 and C1 atoms in the
MurNAc residue. In total, six different lytic transglycosy-
lases (Slt70, MltA–D and EmtA) have been characterized
in Escherichia coli ; they differ in size, sequence, activity,
specificity and location. As inhibition of certain lytic trans-
glycosylases strongly enhances the effect of some β-lactam
antibiotics, the development of lytic transglycosylase
inhibitors is considered to be a valuable approach to
increase the array of effective antibacterial compounds.
The present study describes the crystal structure of the
E. coli lytic transglycosylase Slt35, a soluble 36 kDa
form of the slightly larger outer membrane bound
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Figure 7
Stereoview of the molecular surface of Slt35
with GlcNAc (orange) in the active site and a
model for the exo-loop (residues 99–108; red).
The surface is coloured according to
conservation in the multiple sequence
alignment of MltB transglycosylases shown in
Figure 2: non-conserved residues (dark blue),
similar (green), and identical (white). The
surface of the catalytic acid/base Glu162 is in
yellow. The residues of the exo-loop, which are
currently missing in the X-ray structure, have
been modelled in the program O in a region of
low electron density and refined with X-PLOR.
Structure
lipoprotein MltB (40 kDa). Although Slt35 has no
obvious sequence similarity to Slt70, the only other
structurally characterised lytic transglycosylase, its cat-
alytic domain shows a surprising similarity to that of
Slt70. The active site is very similar as well, with the
exception of one carboxylic residue which is absent in
Slt35, but which in Slt70 probably interacts with the
2-acetamido moiety of the MurNAc residue during catal-
ysis. Nevertheless, the similarity of the active sites of
Slt35 and Slt70 suggests that it might be possible to
develop new antibacterial inhibitors that target several
lytic transglycosylases at once. 
Materials and methods
Crystallisation
For the expression and crystallisation of Slt35, an active 36 kDa
soluble fragment was constructed, which starts at residue 42 with
two additional residues (Met40 and Val41) at the N terminus [15].
Slt35 crystallises in the presence of 0.1 M bicine-NaOH buffer
(pH 7.8–8.5) and 0–6% polyethylene glycol 20,000 (PEG20K) in the
primitive orthorhombic space group P212121 with cell dimensions of
a = 58.3, b = 67.9 and c = 98.9 Å [49]. The value of the Matthews
coefficient, Vm [50], is 2.72 Å3/Da for one molecule per asymmetric
unit. Assuming a partial specific volume for globular proteins of
0.74 cm3/g, the solvent content of the crystals is about 55%. Crystals
were stored in a stabilising solution containing 100 mM bicine-NaOH
buffer (pH 8.0–8.5), 1% isopropanol and 5–10% PEG20K.
GlcNAc soaking experiment
In the native Slt35 structure, a bicine molecule (N, N-bis[2-hydroxy-
ethyl]-glycine) and an ethylene glycol molecule, probably originating
from the PEG20K solution, were observed in the active site. To avoid
any interference with the binding of N-acetylglucosamine (GlcNAc), a
25% (w/v) PEG20K stock solution was dialysed against pure water for
24 h using a membrane with a 6–10 kDa cut-off. The concentration of
the PEG20K was determined with a GPR 11–37 Refractometer (Index
Instruments). An Slt35 crystal was washed in a solution of 50 mM Tris-
HCl buffer (pH 8.0) and 2% of dialysed PEG20K and this was
repeated four times in 30 min. Subsequently, the crystal was soaked
for 18 min in a solution of 50 mM Tris-HCl buffer (pH 8.0), and 2% of
dialysed PEG20K saturated with GlcNAc (Sigma).
Data collection and processing
For diffraction experiments, crystals were flash frozen at 120K in a
stream of evaporating nitrogen after having been soaked for 1 min in a
cryo-protectant consisting of 25–50% glycerol added to the stabilising
or soaking solution. Data to 1.7 Å resolution were collected from a
native Slt35 crystal at the A1 station at CHESS (Cornell High Energy
Synchrotron Source) in Ithaca (USA), using a wavelength of 0.920 Å
and a CCD camera as detector. Slt35–GlcNAc diffraction data were
collected on a DIP 2030H image plate (MacScience) using Cu Kα
radiation from a Nonius FR591 rotating-anode generator with Franks'
mirrors. Data were processed with DENZO and SCALEPACK [51].
Intensities were converted to structure-factor amplitudes with pro-
grams from the Groningen BIOMOL software package. 
In the course of an extensive heavy-atom derivative search, diffraction
data were collected on a FAST area detector (Enraf-Nonius, Delft, The
Netherlands) using Cu Kα radiation from an Enraf Nonius FR571 rotat-
ing-anode generator with a graphite monochromator. Data reduction
was performed with MADNES [52], XDS [53] and BIOMOL programs.
Data for a mercury derivative (Hg-III) were measured at beamline
BW7A of the EMBL Outstation at DESY, Hamburg (Germany), at a
wavelength of 0.970 Å with a MAR Research (Hamburg) imaging plate
as detector. These data were also processed with DENZO and
SCALEPACK. Data collection statistics can be found in Table 1.
Phasing
The structure of Slt35 was solved by the multiple isomorphous replace-
ment method with inclusion of anomalous scattering differences
(MIRAS) (Table 1). Heavy-atom parameters were scaled and refined at
2.7 Å resolution with PHASES [54]. The MIRAS phases were subse-
quently extended to 2.5 Å resolution using the program DM [55] with
solvent flattening and histogram matching. Next the recently developed
wARP procedure [56] was used to improve and extend the phases to
2.0 Å resolution, which resulted in a map that was readily interpretable.
Later, it appeared that the 2.5 Å DM phases could be readily extended to
even 1.7 Å resolution using wARP as described in detail elsewhere [49].
Model building and refinement 
Model building was performed with the interactive graphics program O
[57] on Silicon Graphics workstations. The quality of the wARP map
allowed us to take complete advantage of the model building proce-
dures and especially the real-space refinement capabilities included in
the O package. The model from O was refined at 1.7 Å resolution in
several cycles of simulated annealing (3000–300K), Powell energy
minimisation, overall and individual B-factor refinement with the
program X-PLOR version 3.843 [58] and manual rebuilding. For a test
set, 10% of randomly selected reflections were set aside [59]. At the
end of the refinement, low resolution diffraction data to 20 Å were
included and a bulk-solvent correction was applied. The application of
resolution-dependent and 1/σ2 weighting schemes resulted in lower
Rfree values and smaller differences between Rwork and Rfree.
The native Slt35 model was used as a starting model to refine the
Slt35–GlcNAc complex. The same reflections were selected for the
test set as were used in the refinement of the native data set (10% of
reflections) [59]. After rigid-body refinement (3.5–8.0 Å resolution), the
model was refined in several cycles of Powell energy minimisation,
occupancy refinement of alternate sidechain conformations, overall and
individual B-factor refinement with the program X-PLOR version 3.843
[58]. Solvent molecules and GlcNAc were added to complete the
model. The force constants and parameters used for the sugar were
those described by Weis et al. [60], and as implemented in the
X-PLOR geometry files. Low resolution diffraction data to 20 Å, a bulk-
solvent correction, an anisotropic B-factor scaling and resolution-
dependent and 1/σ2 weighting schemes were included.
The last refinement cycle of both structures was repeated with all data
including the test set. The final refinement statistics for both structures
are summarised in Table 2. Stereochemistry was inspected with the
programs PROCHECK [61] and WHAT CHECK [62]. Surface calcula-
tions were performed with ASC [63] using a probe radius of 1.4 Å. 
Mutagenesis
The codon for Glu162 was exchanged for one coding for a glutamine
residue, using the QuickChange mutagenesis system (Stratagene, La
Jolla, CA). Peptidoglycan hydrolase activity of the expressed mutant
protein was determined using zymogram analysis, and by measuring
the solubilization of radiolabelled peptidoglycan following a published
procedure [15].
Accession numbers
Atomic coordinates have been deposited with the Protein Data Bank
under the accession codes 1QUS for the native structure and 1QUT
for the Slt35 complex.
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